iSpecimen Inc. (ISPC)
Market Cap | 4.44M |
Revenue (ttm) | 10.39M |
Net Income (ttm) | -9.52M |
Shares Out | 962.64K |
EPS (ttm) | -17.63 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 67,137 |
Open | 4.410 |
Previous Close | 4.450 |
Day's Range | 4.360 - 4.800 |
52-Week Range | 3.410 - 12.600 |
Beta | 1.59 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 7, 2024 |
About ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketp... [Read more]
Financial Performance
In 2023, iSpecimen's revenue was $9.93 million, a decrease of -4.56% compared to the previous year's $10.40 million. Losses were -$11.10 million, 8.33% more than in 2022.
Financial StatementsNews
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Biospecimen Market To Exceed $13.5 Billion USD By 2032 Woburn, Massachusetts--(Newsfile Corp. - November 8, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marke...
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members
WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...
iSpecimen Announces 1-for-20 Reverse Stock Split
WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...
iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Phil Carlson - IR, KCSA Strategic Communications Tracy Curley - CEO and CFO Leslie Hoyt - ...
iSpecimen Reports Second Quarter 2024 Results
Revenue increased 76% year-over-year to approximately $2.86 million Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. ...
iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executi...
iSpecimen Reports First Quarter 2024 Results
LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medic...
iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024
LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...
iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript
iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript
iSpecimen Reports Full Year 2023 Results
LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after th...
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Servi...
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medic...
iSpecimen Strengthens Global Oncology Biospecimen Offering
Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research Adds New Suppliers and Expands Existing R...
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Ex...
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Drive...
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Comple...
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Med...
iSpecimen Expands Provider Network to Enhance Support for Women's Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs ...
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions Company to Focus on Core Revenue Drivers, New Re...